Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112677) titled 'Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study' on Aug. 2.
Study Type: Observational
Primary Sponsor: Elham Ahmed Hassan
Condition:
Brucellosis
Low Back Pain
Intervention:
Diagnostic Test: Brucella Antibody Testing (ELISA)
Recruitment Status: Not recruiting
Date of First Enrollment: February 1, 2024
Target Sample Size: 100
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07112677
Published by HT Digital Content Services with permission from Health Daily Digest....